clinical trial

8 May 2025

Aspanoa invests 120.000 euros to promote new immunotherapies for childhood cancer.

It will be distributed equally between two research projects. One is led by Diego Sánchez (IIS Aragón) and the other by Eva Gálvez (CSIC) and Ramón Hurtado (BIFI – Unizar). Immunotherapy is a treatment already being applied to some cancer patients, including children, when standard therapies are insufficient.
November 15, 2024

Jorge Rubio Gracia: “We face a high level of competition to obtain human and economic resources”

In this interview, the IIS Aragón researcher talks about his work leading the 'Heart Failure Research Group' (GIIS043) and what his most notable project is.